Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Committee reviews bill to let schools stock and use intranasal epinephrine and clarify nurse authority

2852370 · April 2, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Representative Leslie Goldman and health officials described a bill that would add intranasal epinephrine to school stock supplies, update protocols for prescribing and training, and shift authority to school nurses to designate personnel to administer emergency epinephrine.

The committee considered a bill to expand school stock-supply authority for epinephrine by adding intranasal epinephrine (a nasal spray formulation) alongside autoinjectors and by clarifying that school nurses — not school administrators — should direct medical delegation and training.

Representative Leslie Goldman, sponsor of the bill as introduced in the House, said the measure arose from a school nurse’s request to update statute so the new intranasal formulation can be used in emergencies. A state health office witness summarized the bill’s two principal changes: allow stock intranasal epinephrine in schools and adjust delegation language so school nurses, rather than administrators, designate and supervise personnel who may administer epinephrine.

Why it matters: The change would let schools maintain a stock supply of intranasal epinephrine or autoinjectors (or both) for emergency use, clarify who may be authorized to administer the medication, and…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans